lapatinib has been researched along with 4-aminoquinazoline in 1 studies
| Studies (lapatinib) | Trials (lapatinib) | Recent Studies (post-2010) (lapatinib) | Studies (4-aminoquinazoline) | Trials (4-aminoquinazoline) | Recent Studies (post-2010) (4-aminoquinazoline) |
|---|---|---|---|---|---|
| 1,919 | 305 | 1,442 | 45 | 0 | 38 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Fattah, MM; Amin, NH; El-Saadi, MT; Mohammed, AA; Said, EG | 1 |
1 other study(ies) available for lapatinib and 4-aminoquinazoline
| Article | Year |
|---|---|
Development of certain aminoquinazoline scaffolds as potential multitarget anticancer agents with apoptotic and anti-proliferative effects: Design, synthesis and biological evaluation.
Topics: Antineoplastic Agents; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; ErbB Receptors; Female; Humans; Kidney Neoplasms; Lapatinib; Lung Neoplasms; Melanoma; Molecular Docking Simulation; Molecular Structure; Structure-Activity Relationship | 2023 |